For authors

Validity from 1 January 2025

  • The editorial office accepts for publication papers dealing with the fields of anaesthesiology, intensive care medicine, pain management, emergency medicine, and resuscitation.
  • Manuscripts are to be submitted only in electronic form via the editorial system.
  • The manuscripts must be submitted in the form of at least three files, the details of which are specified below - title page, manuscript, authors' declaration.
  • Authors who have not yet submitted a manuscript to the editorial system must first register at www.aimjournal.cz, and login credentials will be emailed to them afterwards. Once the manuscript has been entered into the editorial system and all the details have been filled in, the final manuscript must be sent to the editorial office by pressing the appropriate button, otherwise the manuscript will not go through.
  • The journal accepts the following types of articles for publication in the Czech, Slovak, and English (British English preferred) languages: original papers, case reports, and review articles from the field or history of the field; reports on the activities of the ČSARIM and ČSIM societies; information on future and past congresses, symposia, and anniversaries of leaders in the field; and reviews of new publications from the field (the specific features of the individual types of articles should be respected).
  • For interventional studies, an ethics committee approval is required prior to their launch.
  • The manuscripts submitted shall not be returned.
  • The editorial office reserves the right to reject a manuscript in case its format or content fail to meet publication purpose.
  • All manuscripts are subject to language and editorial review.
  • All submitted manuscripts are double peer-reviewed. The peer-review process is conducted electronically via the editorial system, and is blinded to both the authors and the reviewers. The final decision regarding publication is made by the editor-in-chief.
  • Before resubmitting a revised manuscript, the changes made in response to reviewer comments should be highlighted (font colour, emphasis) and a covering letter for the reviewers attached, explaining which changes recommended by the reviewers were or were not made.
  • By publishing the article, the publisher obtains the exclusive copyright to use it.
  • The authors will receive no royalties for publication.

Manuscript composition

Text

Format: Word 2003 and newer versions (doc, docx).

Figures

Location: Figures are attached as separate files; they are not included in the manuscript text file. References should be made in the manuscript text to each figure.

Copyright: All figures must be original; previously copyrighted material may only be published with permission of the copyright holder (must be specified) and redrawn versions of copyrighted material must be accompanied by the following note: freely adapted from… (name of original author and reference number in square brackets; cited in the References list).

Name and legend: Each figure must have its own name and/or legend.

Page one of the manuscript

Mandatory information for each article type:

Article title

It should reflect the content of the article accurately and should not exceed 120 characters (including spaces). It should include no abbreviations.

Author(s)

The name(s) in the form: Surname First name initial followed by a period. All authors should be listed. Indicate the author’s affiliation with a superscript Arabic numeral after the first name initial.

Author affiliation(s)

Only official names may be used as published on the institution’s web site. In the case of several authors with various affiliations, the affiliation number from the author list is used and indicated with a superscript Arabic numeral preceding the institution’s name.

Page two of the manuscript

Summary/Abstract: For articles in the English language, a Summary/Abstract is provided in English only. A Summary/Abstract contains no abbreviations, figure references, and tables.

Key words: A list of 3–6 keywords consistent with the MeSH terminology (https://www.ncbi.nlm.nih. gov/mesh).

Summary/Abstract requirements

Manuscript type Summary/ Abstract type Summary/Abstract maximum length
Original paper structured 250 words
Review article (or equivalent) free-flowing 250 words
Case report free-flowing 200 words
Editorial, correspondence, reports… none 0
Short communication none 0

Structured abstract format

Study Objective: characterizes the issue dealt with in the research, its purpose, hypothesis, etc.

Study Design: e.g., observational, prospective, randomized, double-blind, etc.

Setting: e.g., ICU of a teaching hospital (address and name are not to be included).

Material and Methods: characteristics of the study cohort, inclusion and exclusion criteria, statistical methods used.

Results: the results obtained, including numerical values and statistical significance.

Conclusion: conclusions drawn by the author from the present paper, summary of the main points.

Page three and subsequent pages of the manuscript

= the manuscript itself

Extent of the text itself and maximum number of references

Type of article Maximum extent (words) Max. number of references
Original paper 3,000 25
Review article (or equivalent) 4,500 75
Case report 1,800 10
Short communication 1,500 10

 

Manuscript format

Original Paper

The author presents his or her own findings obtained through experimental or clinical study. The paper is introduced by a structured abstract with keywords.

It is divided into the following sections:

  • Introduction – introduces the issue, the reasons behind choosing the topic, and the objective of the study. In the case of research work, a hypothesis to be confirmed or rejected should be stated.
  • Material and Methods – provides information on the study population / experimental subject, accurate description of the methods used, the statistical method used, and the method of evaluation. In the case of interventional studies, an ethics committee approval (even though ethics committee approval is also stated on the last page) and patient consent to inclusion in the study should be included, or the reasons why approval was not sought should be stated.
  • Results – reports the results consistent with the method(s) described.
  • Discussion – presents the main result and its interpretation, an analysis of the results obtained, an evaluation of possible “weak points” of the study methodology, the authors’ own comment, and a comparison with other authors’ papers which addressed the same issue.
  • Conclusion – a summary of the relevance of the study and an assessment of whether the study objectives were met.

Review Article

Review articles are prepared by an experienced expert in a particular field, typically upon invitation of the editorial office or following a consultation with the managing editor. They provide an overview of current knowledge, including controversial views. They are introduced by a short abstract with keywords.

Case Report

It is a scientific narrative, introduced by a short, free-flowing summary of up to 15 lines (200 words). It consists of the following: Introduction, Case Presentation, Discussion, and References.

In order for case reports to comply with the GDPR, consent for publication must be obtained from the patient (a legal representative, or a relative). This fact shall be indicated on the last page of the manuscript.

Short Communication

The article should deal with the author’s experience with the topic or precisely specify the goal of the communication (not only a review of literature on the topic in question), and/or present some points to remember in order to enhance the previous practice. An abstract is not included. The text may contain one table or figure.

New Guidelines

The journal publishes guidelines of the ČSARIM and ČSIM professional societies as well as guidelines of other professional societies.

Correspondence

Letters to the Editor – introduced by identifying the article which the letter relates to and by the phrase ‘Dear Editor’.

Reports from Professional Societies

Reports from ČSARIM and ČSIM congresses and other major professional events, news from professional societies, or information from ČSARIM and ČSIM committees.

Congress Abstracts

Includes selected summaries of free communications and posters.

References

In-text citations: References must be identified in the text by using an Arabic numeral in square brackets [ ] in the order in which they are cited. References list: References must be numbered consecutively in the order in which they are mentioned in the text; the authors cited in the text must be included in the References list; and at least one-third of the references should be no older than five years. In the case of more than one author, list the first six authors followed by “et al.”.

All items in the References list at the end of the manuscript should follow the format used by PubMed (www.pubmed.com); correct punctuation must be observed (periods, commas, semi-colons, spaces).

Samples of formatted references are available from: https://www.nlm.nih.gov/bsd/uniform_requirements.html

The last page of the manuscript

All items must be completed; if an item is not relevant, the author will indicate N/A. Some of the items may not appear in the published version at the discretion of the editors.

Corresponding author

  • First Name, Last name, Title(s)
  • E mail
  • Mobile phone number (will not be published in the magazine; it is intended to be used for a quick contact between the editor and the author in the case of confusion)

Date

AI Use Statement

To confirm that the autors did not use any form of artificial intelligence in the writing of this scholarly article. All information and analyses must be the results of their research, experience and judgment with emphasis on relevant literature, primary sources and consultation with experts in the field.

Originality stetement

Confirm that the work is original, has not been published or submitted for peer-review in any other medium. It is appropriate to indicate whether preliminary results were presented as a talk, poster, or conference abstract.

Conflict of interest

Indicate whether the authors have / do not have a conflict of interest related to the topic of the paper.

Agree with the article’s content

Confirm that all authors have read the manuscript, and agree to it text and its submission to the editors of Anesteziologie a intenzivní medicína journal.

Indicate the authors' contribution

Indicate by name (initials) how each author contributed to the article. For each author, indicate one or more forms of their contribution using the terms below:

- conceptualization

- methodologies

- personal participation in the conduct of the research or experiment

- writing (original proposal)

- writing (review and editing)

- guidance and coordination

- validation

- formal analysis

- data management

- project administration

- fundraising

Funding

Indicate financial support for the work, e. g. none, institutional support, deparmental resources, grant project.

Acknowledgements

List acknowledgements to those who contributed to the work but do not meet the criteria for co-authorshiop.

Registration in databases

e. g. ClinicalTrials.gov (registration number)

Ethics committee consideration

committee name and registration number

Inclusion in a journal section



In accordance with the Declaration of Helsinki and the requirement of the ICMJE (International Committee of Medical Journal Editors), it is recommended that clinical intervention trials enrolling patients after 1 January 2015 be registered in one of the existing databases (e.g. ClinicalTrials.gov) and approved by the Commission for the Ethical Treatment of Animals in accordance with Act No. 246/1992 Coll., on the Protection of Animals against Cruelty, as amended, and European Union Directive 2010/63/EU.

Proofreading of English language titles, abstracts and keywords of Czech and Slovak articles is the responsibility of the reviewers. Proofreading of articles submitted in English is provided by the editors as part of the editorial proofreading after the article has been accepted for publication.

Ethics committee approval must always be obtained before the start of any interventional or non-interventional study. Exceptions may be made for observational studies, audit results, epidemiological follow-up, etc., but the indicators monitored must be a routine part of the medical record of the population under study. However, even in these cases, the Editorial Board recommends obtaining the opinion of the Ethics Committee before starting the study.

Informed consent for participation in the study and any diagnostic or therapeutic intervention should be obtained from all subjects (or their legal guardians). The decision of the study authors not to require Informed Consent must be thoroughly and convincingly justified in the text of the paper in the section on Set and Methods.

In the case of case reports, the authors must obtain the consent of the patient (or legal guardian or relatives, if otherwise not possible) for publication, especially in cases where the nature of the case or the form of documentation (e.g. photographs) carries a risk of possible patient identification.

The existence of the ethics committee's approval does not preclude the rejection of a paper by the editorial board in the peer review process for ethical reasons.

In case of any questions or doubts regarding the ethical aspects of the planned study, the Editorial Board may be asked for its opinion.

Reviewers must not use AI to prepare the review.

Peer-review process

  • All peer-review process is conducted electronically via the editorial system and typically takes four to six weeks. The authors are notified of the result of the peer-review process electronically by sending two review comments from external reviewers. The authors are asked to address reviewers’ recommendations within their revised manuscript and send a covering letter to each reviewer, explaining uncertainties and answering reviewers’ questions. The final decision regarding publication at the end of the peer-review process is made by the managing editor. The authors are notified of the result of the peer-review process within three months.
  • In accordance with the Helsinki Declaration and the ICMJE (International Committee of Medical Journal Editors) requirement, it is recommended to register interventional clinical studies, which recruited patients after 1 January 2015, with some of the existing databases (e.g., ClinicalTrials.gov).
  • An ethics committee approval must always be obtained prior to the launch of any interventional or non-interventional study. Exceptions include observational studies, audit results, epidemiological observations, etc.; however, the parameters monitored must clearly be a routine part of the medical records of the study population. However, even in these cases, the editors recommend obtaining an opinion of the ethics committee prior to study initiation.
  • An informed consent to participation in a study and to possible diagnostic or therapeutic interventions should be obtained from all individuals (or their legal representatives) who are subjects of the clinical study. The study authors’ decision not to request an informed consent must be thoroughly and convincingly justified in the Material and Methods section of the article.
  • In the case of case reports, consent for publication must be obtained from the patient (a legal representative, or a relative), particularly when the nature of the case or the form of documentation (e.g., photographs) carry a risk of possible identification of the patient.
  • The existence of an ethics committee approval does not preclude the article from being rejected by the Editorial Board in the peer-review process for ethical reasons.
  • Should there be any questions or doubts regarding the ethical aspects of a planned study, it is possible to ask the Editorial Board for an opinion.

Anesteziologie a intenzivní medicína

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.